Novartis Oncology VP of Risk Salaries in Montgomery, AL | Comparably
At Novartis Oncology, we are passionate about the discovery and development of innovative medicines. read more
EMPLOYEE
PARTICIPANTS
14
TOTAL
RATINGS
161

Novartis Oncology VP of Risk Salaries in Montgomery, AL

The average Novartis Oncology VP of Risk in Montgomery, AL earns an estimated $146,531 annually. Novartis Oncology's VP of Risk compensation is $3,576 more than the US average for a VP of Risk.

In Montgomery, AL, The Legal Department at Novartis Oncology earns $3,004 more on average than the Product Department.

Last updated 3 years ago.

$46k
$85k
$116k
$143k
$194k
$250k
$146,531
Average Compensation
$146,531
avg. base

VP of Risk Salaries at Novartis Oncology

In Montgomery, AL, VPs of Risk earn $56,654 more than Contracts Specialists, and $48,049 less than Corporate Counsels.

General Counsel
$212k*
Corporate Counsel
$195k*
Contracts Specialist
$90k*
Paralegal
$70k*
* estimated salary

Compensation at Novartis Oncology by Department

In Montgomery, AL, The Legal Department averages $3,004 more than the Product Department, and $44,054 less than the Communications Department

Communications
$185,840 Avg. total comp.
+$44k
Legal
$141,786 Avg. total comp.
Product
$138,782 Avg. total comp.
-$3k

VP of Risk Compensation by Gender (All Companies)

The average female VP of Risk at companies similar size to Novartis Oncology reported making $104,000, while the average male VP of Risk at similar sized companies reported making $157,000.

VP of Risk Compensation by Ethnicity (All Companies)

The average Hispanic or Latino VP of Risk at companies similar size to Novartis Oncology reported making $160,000, while the average Caucasian VP of Risk at similar sized companies reported making $132,000.

How VPs of Risk at Novartis Oncology Rate Their Compensation

The majority of VPs of Risk at Novartis Oncology believe they're not compensated fairly. 100% of VPs of Risk at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology

×
Rate your company